Trial intelligence / Profile preview

Honey and Hydrogel Products for Diabetic Foot Ulcers

NCT03816618Phase 1Completed

Sponsor
University of Cyberjaya
Start
Jan 2020
Primary completion
Feb 2023
Modality
Hydrogel Systems, Transdermal Patches
Countries
1
01

Overview

Phase 1, randomised, single-blind trial of Medihoney Derma Cream and Purilon in diabetic foot ulcer (DFU) (4 arms), sponsored by University of Cyberjaya. Primary endpoints: Time needed to reach the condition of fully healing of the ulcer and Ulcer Size. Started Jan 2020; status: completed.

02

Drugs

Medihoney Derma CreamPurilon
03

Conditions

diabetic foot ulcer (DFU)

Beyond the preview

Go deeper on NCT03816618.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03816618.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call